Cencora Strengthens Board with Appointment of Ellen Cooper
Cencora, Inc. (NYSE: COR) has announced a significant addition to its Board of Directors with the election of Ellen Cooper as an independent director, effective January 20, 2026. This strategic move aims to bolster the company’s governance and enhance its long-term growth prospects in the competitive healthcare landscape.
1. A Leader in the Insurance Sector
Ellen Cooper brings a wealth of experience and a robust background in risk management and financial strategy to Cencora. Currently serving as the Chairman, President, and Chief Executive Officer of Lincoln Financial, Cooper's appointment is expected to provide invaluable insights into navigating the complexities of the healthcare market.
Before her tenure at Lincoln Financial, which began in May 2022, Cooper held several senior roles, including Executive Vice President and Chief Investment Officer. She also led Enterprise Risk and Annuity Solutions, showcasing her versatility in managing both investment strategies and risk assessments.
Her previous experience includes a significant role at Goldman Sachs Asset Management as Managing Director and Global Head of Insurance Strategy and serving as Chief Risk Officer for AEGON Americas. With a career foundation at Ernst & Young LLP, her extensive expertise positions her as a formidable addition to Cencora’s Board.
2. Strategic Insights from Cencora’s Leadership
Mark Durcan, Chair of Cencora’s Board of Directors, expressed enthusiasm about Cooper’s election, stating, “Ellen’s expertise in risk management and experience as a leader in a regulated and complex industry will build upon the Board’s ability to continue to support Cencora’s long-term sustainable growth.” This sentiment reflects the board's commitment to enhancing its depth and breadth as it navigates the future of healthcare solutions.
Cencora's President and CEO, Robert P. Mauch, echoed this sentiment, highlighting Cooper’s strategic acumen within the insurance sector. He remarked, “Ms. Cooper is a recognized leader in the insurance industry with strong strategic acumen and financial experience. She brings valuable perspective as Cencora enhances our position as a leading healthcare company.”
3. Educational and Professional Credentials
Ellen Cooper’s credentials are as impressive as her career. She holds a Bachelor of Business Administration from Temple University and is a Fellow of the Society of Actuaries. Furthermore, she is a Chartered Enterprise Risk Analyst and a Chartered Financial Analyst charter holder, reflecting her deep understanding of financial principles and risk management.
In addition to her role at Cencora, Cooper serves on the Executive Committee of the American Council of Life Insurers and the Board of Trustees of Temple University, underlining her commitment to both the industry and education.
4. About Cencora
Cencora is a leading global pharmaceutical solutions organization dedicated to improving the lives of people and animals worldwide. With a focus on partnering with pharmaceutical innovators, Cencora facilitates and optimizes market access to therapies. The company stands out for its secure and reliable delivery of pharmaceuticals and healthcare products, supported by a dedicated team of over 51,000 employees globally. Ranked #10 on the Fortune 500 and #18 on the Global Fortune 500, Cencora boasts more than $300 billion in annual revenue, reflecting its significant impact in the healthcare sector.
As the company continues to advance its mission of creating healthier futures, Cooper’s addition to the Board is poised to strengthen its leadership and strategic direction in an ever-evolving market landscape.
